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Abstract
Background: Polyketides are structurally diverse natural prod-
ucts with a wide range of useful activities. Bacterial modular
polyketide synthases (PKSs) catalyse the production of non-
aromatic polyketides using a different set of enzymes for each
successive cycle of chain extension. The choice of starter unit is
governed by the substrate specificity of a distinct loading module.
The unusual loading module of the soraphen modular PKS, from
the myxobacterium Sorangium cellulosum, specifies a benzoic acid
starter unit. Attempts to design functional hybrid PKSs using this
loading module provide a stringent test of our understanding of
PKS structure and function, since the order of the domains in the
loading and first extension module is non-canonical in the
soraphen PKS, and the producing strain is not an actinomycete.
Results : We have constructed bimodular PKSs based on
DEBS1-TE, a derivative of the erythromycin PKS that contains
only extension modules 1 and 2 and a thioesterase (TE) domain,
by substituting one or more domains from the soraphen PKS. A
hybrid PKS containing the soraphen acyltransferase domain
AT1b instead of extension acyltransferase domain AT1 produced
triketide lactones lacking a methyl group at C-4, as expected if
AT1b catalyses the addition of malonyl-CoA during the first
extension cycle on the soraphen PKS. Substitution of the DEBS1-
TE loading module AT domain by the soraphen AT1a domain led
to the production of 5-phenyl-substituted triketide lactone, as well
as the normal products of DEBS1-TE. This 5-phenyl triketide
lactone was also the product of a hybrid PKS containing the entire
soraphen PKS loading module as well as part of its first extension
module. Phenyl-substituted lactone was only produced when
measures were simultaneously taken to increase the intracellular
supply of benzoyl-CoA in the host strain of Saccharopolyspora
erythraea.
Conclusions: These results demonstrate that the ability to recruit
a benzoate starter unit can be conferred on a modular PKS by the
transfer either of a single AT domain, or of multiple domains to
produce a chimaeric first extension module, from the soraphen
PKS. However, benzoyl-CoA needs to be provided within the cell
as a specific precursor. The data also support the respective roles
previously assigned to the adjacent AT domains of the soraphen
loading/first extension module. Construction of such hybrid
actinomycete^myxobacterial enzymes should significantly extend
the synthetic repertoire of modular PKSs. ß 2001 Elsevier Sci-
ence Ltd. All rights reserved.
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1. Introduction
Macrocyclic polyketides form a large and structurally
diverse class of natural products and include numerous
clinically important antibacterial, antifungal, anthel-
minthic, antitumour and immunosuppressant compounds.
They are synthesised on type I modular polyketide syn-
thases (PKSs) that consist of giant multienzymes [1^8]
housing sets or modules of enzymatic activities. Each
module contains the enzymatic domains required to cata-
lyse a particular cycle of polyketide chain extension and,
where appropriate, L-keto processing. For chain extension,
an acyltransferase (AT) domain selects the appropriate
dicarboxylic acid, activated as its coenzyme A (CoA) ester.
For chain initiation, starter units derived from monocar-
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boxylic acids are selected by one of several alternative
mechanisms, as explained below. The enzymatic activities
that govern chain initiation are housed in a dedicated
loading module (LM or Mod0) located immediately adja-
cent to the ¢rst extension module, normally as part of the
same multienzyme protein but in some cases as a discrete
entity [9^11]. Likewise, there is normally a dedicated do-
main C-terminal of the ¢nal extension module that gov-
erns chain termination, consisting often of a thioesterase
(TE) domain which may act as a cyclase. Alternatively, the
fully extended acyl chain may serve as the substrate for
further enzymes, as in the biosynthesis of rapamycin where
an amino acid is added by a module of non-ribosomal
peptide synthetase activities [4,12].
Most of the biosynthetic gene clusters for macrocyclic
polyketides that have been sequenced so far have been
cloned from the actinomycete order of Gram-positive bac-
teria [13], and each PKS has proved to be closely pat-
terned on the structure originally described for the 6-de-
oxyerythronolide B synthase (DEBS) of Saccharopolyspora
erythraea which produces the precursor of the 14-mem-
bered macrolide antibiotic erythromycin A (Fig. 1).
More recently, several modular PKS clusters have been
identi¢ed from non-actinomycete bacteria, and they often
show puzzling di¡erences in the organisation of their mod-
ules, from the canonical organisation established for strep-
tomycete PKSs, which have yet to be satisfactorily ex-
plained. For example, the PKSs found in the Bacillus
genome (accession number AL009126) apparently contain
no integral extender AT domains, and this is also a feature
of the putative pseudomonic acid synthase from Pseudo-
monas £uorescens [14].
Other modular PKSs have been recently characterised
from the Gram-negative myxobacteria [15,16]. These in-
clude those for the antifungal soraphen [17] (Fig. 1) and
the antitumour compound epothilone [18,19], both ob-
tained from di¡erent strains of Sorangium cellulosum.
The sequence of the soraphen biosynthetic gene cluster is
available in the patent literature (EMBL accession number
I88042). It contains two type I modular PKSs, SorA and
SorB. An unusual feature of this PKS is the lack of a
clearly demarcated loading module for the unusual ben-
zoate starter unit. Instead, the domains of the loading and
¢rst extension module appear to be combined together, so
that the AT domain of the loading module is located with-
in the ¢rst extension module. Recent genetic engineering
of PKSs to create novel antibiotics has heavily emphasised
the key role of chain initiation [20] and a number of novel
antibiotics have been made by this route [21,22]. We there-
fore hoped that a closer investigation of the loading mod-
ule of the soraphen PKS would not only yield insight into
the role of individual domains in the scrambled loading
module, but might also provide an alternative route to the
biosynthesis of hybrid macrolides from a benzoate starter
unit.
The starter units for most complex polyketides are de-
rived from simple aliphatic acids such as acetate and
propionate. These are selected, as shown in Fig. 2, by an
Fig. 1. The structures of soraphen A and erythromycin A. The starter
ketide units introduced by the respective loading modules are high-
lighted.
Fig. 2. Mechanisms of chain initiation on modular PKSs: (A) acyltrans-
fer from an acyl-CoA ester to an acyl carrier protein (ACP) domain cat-
alysed by an AT domain; (B) acyltransfer from the CoA ester of a di-
carboxylic acid to an ACP domain catalysed by an AT domain,
followed by in situ decarboxylation mediated by the KSQ domain; (C)
ATP-dependent activation of a carboxylic acid to an acyladenylate, fol-
lowed by transfer to an ACP domain. KS, L-ketoacyl synthase; KR, L-
ketoacyl reductase; DH, dehydratase; ER, enoylreductase; TE, thioes-
terase; CoL, CoA ligase-like enzyme; KSQ, KS-like domain with gluta-
mine (Q) substituted for the active site cysteine residue; R1, Me or Et;
R2, Me or H.
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N-terminal loading module which may consist either of an
AT followed by an acyl carrier protein (ACP) domain [23],
as in erythromycin or avermectin; or more commonly of
KSQ, AT and ACP domains, where the AT recruits a
dicarboxylic acid onto the ACP and the KSQ domain
accomplishes its in situ decarboxylation [24]. More com-
plex moieties, for example the alicyclic and aromatic start-
er units of rapamycin and rifamycin respectively, are se-
lected by CoA ligase-like domains which activate the
carboxylic acid to the corresponding acyl adenylate, using
ATP, before their covalent attachment to the loading
module via an ACP domain [4,25,26].
Here we show that when the N-terminus of the sora-
phen PKS, bearing the loading module and most of the
¢rst extension module, was fused to an appropriately trun-
cated version of DEBS1-TE, the chimaeric enzyme was
capable of synthesising low levels of the predicted 5-phenyl
triketide lactone. When the AT1a domain alone was
moved to the orthodox position for a loading AT in the
DEBS1-TE system (Fig. 3), the phenyl-substituted product
was also detected. Likewise, the AT1b domain was found
to substitute for the function of the ¢rst extension AT
domain within the DEBS1-TE. These results accord with
predictions made on the basis of alignments of their re-
spective protein sequences with authentic loading and ex-
tender AT domains from other PKSs. The low yields of
novel hybrids obtained are due at least in part to the
di⁄culty of providing adequate intracellular levels of the
benzoate precursor.
2. Results and discussion
2.1. Comparisons of the protein sequences of type I
PKS AT domains
The crystal structure of the malonyl-CoA:ACP AT of
the Escherichia coli fatty acid synthase [27] reveals that
arginine residue 117 lies in the active site, where it might
provide an ionic interaction with the carboxy group of the
malonyl-CoA substrate, and favour the binding of this
over the alternative substrate for this AT, acetyl-CoA.
Smith and his colleagues [28] have shown, using site-di-
rected mutagenesis, that the counterpart of this speci¢c
arginine residue in animal fatty acid synthase AT indeed
contributes to the discrimination in favour of carboxylated
over non-carboxylated CoA substrates. The alignment in
Fig. 4 shows, strikingly, that in the AT domains of the
loading modules of avermectin PKS (AVES) and erythro-
mycin PKS (DEBS), which are the only loading module
ATs known to be speci¢c for non-carboxylated aliphatic
CoA derivatives [23,29,30], the arginine at this position is
replaced in both cases by a tryptophan residue.
Similar considerations can be used for preliminary as-
signment of roles to the two N-terminal SorA AT do-
mains. When the protein sequences of these two ATs (des-
ignated AT1a and AT1b) are included in the sequence
alignment (Fig. 4), there are signi¢cant di¡erences between
the two. First, AT1a is most similar to the loading AT
domains of AVES and DEBS, while AT1b is grouped with
malonyl-CoA-speci¢c extender ATs. Speci¢cally, at posi-
tion 117 (E. coli numbering) AT1b has an arginine residue,
while, in contrast, AT1a has a tyrosine residue. On this
basis, AT1a is proposed to be speci¢c for benzoyl-CoA
and to select the starter unit, while AT1b selects malon-
yl-CoA and this results in the observed incorporation of
acetate into soraphen as the ¢rst act of chain extension
[31] (Fig. 3).
2.2. Production of 5-phenyl triketide lactones by a hybrid
bimodular PKS incorporating both sor AT domains
into DEBS1-TE
Initially, we attempted to introduce the soraphen load-
ing module and part of the ¢rst extension module of the
soraphen PKS into DEBS1-TE, replacing the ¢rst four
domains of DEBS1-TE so as to preserve the unorthodox
protein architecture in the resulting hybrid triketide lac-
Fig. 3. Domain organisation of (A) multienzyme DEBS1-TE derived
from the erythromycin-producing PKS and (B) multienzyme SorA,
which catalyses chain initiation and two rounds of chain extension on
the soraphen-producing PKS. The proposed function of individual AT
domains in initiation is shown.
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tone synthase. This synthase, TKSCJW1, contains both
SorA AT1a and AT1b. The fusion site between SorA
and DEBS1-TE lies between SorA AT1b and the DEBS
KR1 [32], so the ¢rst extension module is chimaeric. If the
SorA domain arrangement is required for incorporation of
benzoate as starter unit and acetate as extender unit re-
spectively, then the lactone 5 (Fig. 5) is the expected prod-
uct.
An S. erythraea strain JC2 [33], from which the DEBS
genes have been deleted, was transformed with pCJW38,
an expression vector for TKSCJW1 based on the integra-
tive plasmid pCJR24 [33]. The resulting recombinant
strain appeared to make no lactone products, as judged
by GC-MS analysis of extracts of culture broths (data not
shown). One plausible reason for this is the lack of provi-
sion within the cells of the speci¢c precursor of benzoate
units, assumed to be benzoyl-CoA. There is no evidence
that S. erythraea generates benzoyl-CoA as part of its
normal metabolism. In parallel, therefore, S. erythraea
JC2 was transformed with a plasmid (pCJW40) that con-
tained both the hybrid TKS gene TKSCJW1 and the badA
gene from Rhodopseudomonas palustris. This anaerobic
bacterium can use benzoic acid as sole carbon source,
and has a dedicated gene cluster to enable it to utilise
benzoic acid [34]. The ¢rst enzyme in this catabolic path-
way is BadA, an ATP-dependent benzoic acid:CoA ligase
[35]. A clone of this gene, pPE202, was the kind gift of
Professor Caroline S. Harwood, Department of Microbi-
ology, University of Iowa, Iowa City, IA, USA. The badA
gene was expressed under the strong, constitutive pro-
moter, PermE [36] (Fig. 6).
S. erythraea JC2 cells transformed with plasmids con-
taining this gene cassette were grown in SM3 medium with
a 3 mM ¢nal concentration of sodium benzoate. Concen-
trations higher than this were found to retard or even
completely inhibit the growth of S. erythraea on solid
medium (data not shown). This recombinant strain ini-
tially appeared to make none of the expected lactones.
However, analysis by the more sensitive method of GC-
MS/MS revealed a small peak (by relative ion current)
that had the same retention time and mass spectrum as
the synthetic standard (Fig. 7). This peak was not present
in a control strain which lacked the badA gene or was not
fed with benzoate (data not shown). The expected ben-
zoate starter lactone product had therefore been produced,
albeit at less than 0.2 mg/l, representing less than 0.5% of
normal rates of triketide production by a control strain
containing DEBS1-TE under the same conditions.
Analysis using SDS^PAGE of cell extracts of the re-
combinant S. erythraea did not reveal the presence of sig-
ni¢cant levels of a high molecular weight protein, indicat-
ing that poor expression levels of the hybrid PKS were
also an important contributing factor in the poor produc-
tion of the expected lactone. We therefore turned to ex-
Fig. 4. Comparison of the protein sequences of AT domains. Loading module ATs are in red, bold font; the soraphen-producing PKS ATs of unknown
speci¢city and role are in green, bold font. The speci¢city motif is de¢ned by Haydock et al. [59] ; the arginine residue conserved in all ATs speci¢c for
(methyl)malonate (blue) was observed by Rangan et al. [28]. DEBS, erythromycin PKS; RAPS, rapamycin PKS; SORS, soraphen PKS; OLES, olean-
domycin PKS; TYLS, tylosin PKS; RnovMAAT, rat fatty acid synthase AT; EcoMCAT, E. coli fatty acid synthase AT.
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amining DEBS1-TE hybrids in which individual sor PKS
AT domains have been introduced, both to con¢rm their
individual roles in the soraphen PKS, and possibly to ob-
tain more stable and productive hybrids.
2.3. AT1b of the soraphen PKS functions as an
extender module AT in DEBS1-TE
Using the system of Oliynyk et al. [32], AT1b of the
soraphen PKS was substituted for AT1 of DEBS1-TE.
S. erythraea JC2 cells expressing this synthase, TKSCJW4,
produced the expected C4 desmethyl triketide lactones
that would result from incorporation of acetate as the ¢rst
extension unit, as judged by GC-MS analysis. Yields were
low, around 0.5 mg/l, less than 1% of the levels of triketide
lactones normally produced under these conditions by
DEBS1-TE. The simplest explanation for these results is
that the introduced AT either decreases the stability of the
hybrid PKS, or is not correctly folded against the £anking
domains. Despite this, these data serve to establish that
AT1b of the soraphen PKS can indeed function as a bona
¢de extender AT with the expected speci¢city for malonyl-
CoA.
2.4. Production of 5-phenyl triketide lactones by a hybrid
bimodular PKS incorporating the sor AT1a domain in
place of the loading module AT of DEBS1-TE
Restriction sites were engineered in the gene for DEBS1-
TE, £anking the sequence for the loading module AT, to
allow this domain to be speci¢cally replaced by the sor
AT1a domain. These sites were introduced in the same
positions as those £anking the DNA sequence of AT1 of
DEBS1-TE in the engineered synthases produced by Oliy-
nyk et al. [32]. In that work, an MscI site was introduced
without alteration in the encoded amino acid sequence at
the margin of the highly conserved N-terminus of the AT
domain. An AvrII site was introduced in the sequence for
the interdomain region C-terminal of the AT domain,
again without changing the encoded amino acid sequence.
In the DEBS loading module AT, the protein sequence at
this C-terminal splice site is not conserved between the
DEBS and sor AT domains. Introduction of the AvrII
site was therefore mutagenic (altering amino acids from
DD to LG). It was important to determine if this was
detrimental to enzyme activity, especially since charged
residues had been replaced with hydrophobic ones. In a
Fig. 5. Domain organisation of DEBS1-TE (Cortes et al., [60]), TKSCAM1 (Oliynyk et al. [32]), and the TKSs constructed in this study. Domains
from the soraphen PKS are in red; rapamycin AT2 is in green.
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control experiment, S. erythraea JC2 cells expressing this
mutated synthase were found to produce the expected tri-
ketide lactones in vivo in yields that were qualitatively
similar (40^50 mg/l) to those from strains expressing
DEBS1-TE. The apparent indi¡erence of the PKS to the
introduced mutations presumably re£ects the fact that
they occur in a mobile £exible linker region [37].
The loading module AT (AT0) of DEBS1-TE was then
replaced with AT1a of SorA and the hybrid enzyme ex-
pressed in S. erythraea JC2. GC-MS analysis of the culture
broths revealed three triketide lactones to have been pro-
duced (Fig. 7). One was the expected benzoate starter
lactone, whose identity was con¢rmed by comparison
with a synthetic standard. The other two triketide lactones
had incorporated the starter units normally selected by the
DEBS loading module, that is, propionate and acetate
respectively. All of these three products were again present
in low yield, less than 1% of the levels of triketide lactones
normally produced under these conditions by DEBS1-TE.
This experiment was repeated in the absence of badA.
The polyketide products of this strain, S. erythraea
JC2: :pCJW45, were lactones with either an acetate or
propionate starter but not with a benzoate starter, as
judged by GC-MS and GC-MS/MS analysis of broth ex-
tracts (Fig. 7). BadA was therefore directly shown to be
important in the supply of substrate to the TKS. Unfortu-
Fig. 6. Map of pCJW47, plasmid used for co-expression of the hybrid
synthase TKSCJW3 (red) and of badA (blue). tsr, thiostrepton resistance
gene; actII-ORF4 and PactI=III , Streptomyces coelicolor actinorhodin
cluster activator^promoter system; oripUC, pUC18 origin of replication;
bla, ampicillin resistance gene.
Fig. 7. The total ion current of typical GC-MS traces of ethyl acetate extracts from (A) S. erythraea : :pCJW40; (B) S. erythraea : :pCJW49; (C) S. ery-
thraea : :pCJW47. The structures of the compounds producing the peaks highlighted are also shown together with their mass spectra.
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nately, the toxicity of sodium benzoate limited the use of
higher concentrations of this precursor in the medium.
An alternative means of supplying the loading AT with
substrate was sought, in the form of the N-acetylcyste-
amine (NAC) thioester of benzoic acid (7). NAC thioesters
act as CoA mimics and can di¡use into the cell [38^41].
When S. erythraea JC2: :pCJW47 cells were fermented in
the presence of this compound, the relative levels of the
5-phenyl triketide lactone 5 appeared to increase as judged
by GC-MS and GC-MS/MS (Fig. 7), again indicating that
substrate supply to AT1a is contributing to limit the yields
in this system. Recent work on the origin of the benzoate
starter of the PKS for the aromatic polyketide enterocin
[42,43] has revealed that the biosynthetic gene cluster con-
tains genes not only for a BadA analogue, but also for
phenylalanine ammonia lyase. In future, co-expression of
a heterologous phenylalanine ammonia lyase gene in S.
erythraea may provide a more e⁄cacious way to enhance
the intracellular pool of benzoate, since cinnamate pro-
duced from L-phenylalanine is readily catabolised to ben-
zoic acid. Similarly, feeding the relevant bacterial host
strain phenyl-substituted fatty acids with an odd-num-
bered chain length may o¡er a route to the generation
in the cell of benzoyl-CoA and derivatives through the
L-oxidation pathway, which itself was investigated using
such compounds in the very ¢rst biochemical labelling
experiments by Franz Knoop in 1904 [44].
2.5. The hybrid loading module containing the sor
AT1a domain is required for incorporation of
benzoate starter units by DEBS1-TE
Propionate starter units have previously been shown to
be incorporated by the DEBS through direct loading onto
the ketosynthase active site in extension module 1 [45]
(N. Dunster and P.F. Leadlay, unpublished data). If the
hybrid loading module containing the sor AT1a domain is
not functioning e⁄ciently, possibly due to problems with
protein interactions, dimerisation, or substrate supply, this
alternative route for chain initiation might be favoured,
and could readily account for the appearance of lactones
1 and 2 in these experiments, without having to postulate
that the sor AT1a is able to accommodate propionyl- and
acetyl-CoA as substrates as well as benzoyl-CoA.
To test for such ‘direct loading’ as a mechanism for the
generation of the benzoate starter lactone, a version of
DEBS1-TE containing an inactive ACP domain in the
loading module was studied in vivo under the same con-
ditions. pND4 is a pCJR24-based expression plasmid for a
DEBS1-TE derivative in which the loading module ACP
(ACP0) has been inactivated by mutation of a speci¢c
serine residue to alanine, abolishing the phosphopante-
theine attachment site. In vivo, this mutant enzyme makes
small (less than 5% of normal levels) amounts of acetate
and propionate starter triketide lactones (N. Dunster and
P.F. Leadlay, unpublished data). Since the perturbation of
the protein structure by this point mutation and hence the
e¡ects on expression and folding of the PKS are expected
to be very small, these data give an indication of the levels
of direct loading that occur when the loading module is
totally inactivated.
S. erythraea JC2: :pND4 cells were grown in SM3 me-
dium supplemented with benzoyl-NAC. When crude ex-
tracts of these broths were analysed by GC-MS both lac-
tones 1 and 2, bearing respectively a propionate and an
acetate starter unit, were observed at levels previously
found without supplementation. No benzoate starter lac-
tone was observed, within the limits of detection (data not
shown), indicating that the 5-phenyl triketide lactone 6 is
unlikely to have arisen by direct loading onto KS1.
3. Perspective
The results of these experiments taken together establish
that in principle functional hybrid PKSs constructed from
myxobacterial DNA and actinomycete DNA can be cre-
ated and used to make novel polyketides, which might
considerably increase the structural diversity of the prod-
ucts that can be obtained by PKS engineering. However,
in order to realise this potential, it is clear from this work
that improvements to the levels of expression of the hybrid
proteins are required; as well as the engineering of appro-
priate metabolic pathways to provide an intracellular sup-
ply of speci¢c building blocks such as benzoyl-CoA, be-
fore these procedures can be carried out on a preparative
scale. Alternative routes to such products have already
been described or may become available, either through
feeding of the appropriate diketide NAC thioesters to
PKSs in which KS1 has been inactivated [46] or through
the use of other heterologous loading modules such as
avermectin [29], rifamycin [26,47] or rapamycin [48].
Nevertheless, study of these hybrid synthases has pro-
vided support for the proposed functions of the SorA
AT1a and AT1b domains. It has also been possible to
separate the two ATs and still maintain their respective
function. On the available evidence, the 5-phenyl triketide
lactone is the product of a conventional mechanism for
chain initiation in which the benzoyl moiety is transferred
to the loading module ACP by the soraphen PKS AT1a.
Sequencing of other myxobacterial PKS gene clusters
has revealed the same unusual tandem arrangement of
AT domains in the loading and ¢rst extension modules,
even where the starter unit is an aliphatic carboxylic acid
such as 3-methylbutyrate [16]. If the folding of the PKS
allows the active site of the loading AT1a domain to be
reached directly by the swinging arm of the loading ACP,
this must require a three-dimensional arrangement of do-
mains within the myxobacterial enzymes that is rather
di¡erent from current models for modular PKS structure
[49,50].
These results have also strengthened the view that argi-
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nine 117 (E. coli numbering) is an important residue for
the ability of PKS AT domains to discriminate between
the CoA esters of mono- and dicarboxylic acids. In those
systems whose mechanism of chain initiation is unclear
[9,10], the loading module AT also contains an arginine
residue at this position. Structural and kinetic experiments
with highly puri¢ed domains in vitro, together with site-
directed mutagenesis, will be required to quantify the con-
tribution of this residue and establish its mechanistic im-
portance.
4. Signi¢cance
Modular PKSs are responsible for the biosynthesis of a
wide range of clinically important natural products, in-
cluding antibacterial, antitumour, antiparasitic and immu-
nosuppressant compounds. They are increasingly being
uncovered in bacteria other than the actinomycetes, with
the myxobacteria proving to be a particularly rich source
of such multienzymes. We have shown here that it is pos-
sible to analyse the speci¢city of individual myxobacterial
AT domains, implicated in chain initiation and the ¢rst
round of chain extension, by transplanting them into a
well-characterised actinomycete PKS test system derived
from the erythromycin-producing PKS. Our results sup-
port the view that benzoate units are recruited by the
soraphen PKS by a conventional mechanism involving
acyl transfer from benzoyl-CoA, or its equivalent, to an
ACP domain. The synthesis of detectable amounts of
5-phenyl triketide lactone by the hybrid enzymes shows
in principle how we can further increase the structural
diversity of products from engineered modular PKSs by
creating such hybrids. At the same time, the high-level
expression of these hybrid PKSs and the intracellular pro-
vision of their precursors remain signi¢cant challenges if
these opportunities are to be fully exploited.
5. Materials and methods
5.1. Strains
All DNA manipulations were performed in E. coli DH10B
(Gibco) using standard culture conditions [51]. E. coli cells were
transformed by electroporation [52]. S. erythraea JC2 [33] was
used as host for expression of PKS genes.
5.2. Plasmids
pUC18 [53], pSET152 [54] and pCJR24 [33] were used as clon-
ing and expression vectors. pCJR26 was from Rowe et al. [33].
pVKM15 was obtained from the NRRL culture collection.
pIB139 and pPFL28, whose construction will be described else-
where, were the kind gifts of Drs I. Bo«hm and P.F. Long. The
details of construction of other plasmids are given below.
psormod1: pVKM15 was digested with BglII and HindIII. The
fragment that encodes SorA module 1 was isolated and ligated to
BamHI-HindIII pUC18 backbone.
pCJW31: a fragment encoding SorA domains 1^3 was ampli-
¢ed by PCR using psormod1 as template and oligonucleotides
oCJW4.1 and oCJW4.2 as primers. The fragment was 5P-phos-
phorylated with T4 polynucleotide kinase and ligated to SmaI-
and SAP-treated pUC18.
pCJW33: a fragment encoding the SorA AT1b was ampli¢ed
by PCR using psormod1 as template and oligonucleotides
oCJW4.5 and oCJW4.6 as primers. The fragment was 5P-phos-
phorylated with T4 polynucleotide kinase and ligated to SmaI-
and SAP-treated pUC18.
pCJW34: a fragment encoding badA was ampli¢ed by PCR
using pPE202 as template and oligonucleotides oCJW4.3 and
oCJW4.4 as primers. The fragment was 5P-phosphorylated with
T4 polynucleotide kinase and ligated to SmaI- and SAP-treated
pUC18.
pCJW35: pCJW31 and pCJW33 were both digested with MscI
and EcoRI. The fragment encoding SorA AT1b was ligated to the
backbone of pCJW31.
pCJW36: pIB139 and pCJW34 were both digested with NdeI
and EcoRI. The badA fragment was ligated to the backbone of
pIB139. This places badA under the control of PermE. This plas-
mid encodes the badA expression cassette.
pCJW38: an PacI-AvrII fragment encoding SorA domains 1^4
from pCJW35 was ligated to AvrII-PacI pCJR26 backbone.
pCJW40: pCJW38 and pCJW36 were both digested with Hin-
dIII. The badA expression cassette was ligated to pCJW38. Ori-
entation: badA is transcribed in the same direction as tsr.
pCJW41: a fragment encoding the N-terminal V100 amino
acids of DEBS1 was ampli¢ed by PCR using pKW9 as template
and oligonucleotides oCJW4.9 and oCJW4.10 as primers. The
fragment was 5P-phosphorylated with T4 polynucleotide kinase
and ligated to SmaI- and SAP-treated pUC18.
pCJW42: a fragment encoding the SorA AT1a was ampli¢ed
by PCR using psormod1 as template and oligonucleotides
oCJW4.7 and oCJW4.8 as primers. The fragment was 5P-phos-
phorylated with T4 polynucleotide kinase and ligated to SmaI-
and SAP-treated pUC18.
pCJW43: pCJW41 and pCJW42 were both digested with MscI
and EcoRI. The fragment encoding Sor AT1a was ligated to the
backbone of pCJW41.
pCJW44: pPFL28 and pCJW43 were both digested with NdeI
and AvrII. The fragment encoding DEBS1 N-terminus-Sor AT1a
was ligated to the backbone of pPFL28. This plasmid encodes
TKSCJW3 as an NdeI-XbaI fragment.
pCJW45: pCJR24 and pCJW44 were both digested with NdeI
and XbaI. The fragment encoding TKSCJW3 was ligated to the
backbone of pCJR24. This plasmid is an expression plasmid for
TKSCJW3.
pCJW47: pCJW40 and pCJW47 were both digested with SpeI
and EcoRI. The fragment encoding actII-ORF4 ;Pact ;TKSCJW3
was ligated to the backbone of pCJW40. This plasmid is an ex-
pression plasmid for TKSCJW3 that also includes the badA ex-
pression cassette from pCJW36. Orientation: badA is transcribed
in the same direction as tsr.
pCJW49: an MscI-AvrII fragment encoding SorA AT1b from
pCJW33 was ligated to AvrII-MscI pCJR26 backbone.
pCJW80: pCJW45 and pCJW80 were digested with MscI and
AvrII and the fragment encoding DEBS AT0 ligated to pCJW45
plasmid backbone. This is an expression plasmid for TKSCJW8.
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This is a DEBS1-TE derivative, the gene for which has unique
MscI and AvrII sites £anking the loading module AT.
pCJW81: a fragment encoding the DEBS AT0 was ampli¢ed
by PCR using pCJR65 as template and oligonucleotides oCJW8.1
and oCJW8.2 as primers. The fragment was 5P-phosphorylated
with T4 polynucleotide kinase and ligated to SmaI- and SAP-
treated pUC18. Orientation: anti.
pIB139: this plasmid is derived from pSET152. PermE was
cloned by PCR introducing an NdeI site overlapping the start
codon downstream of the promoter. This fragment was then in-
serted into the multiple cloning site of pSET152 as an XbaI frag-
ment.
pPFL28: this plasmid encodes a DEBS1-TE derivative with
AT2 from the rapamycin PKS fused to DEBS1-TE before
ACP0. The splice site is an AvrII recognition sequence in the
same position in pCJW43.
5.3. Oligonucleotides
The following synthetic oligonucleotides were used in this study
(incorporated restriction sites are shown in bold): oCJW4.1,
5P-TTAATTAAGGAGGACACATATGACAAAGGAGTACAC-
GCGTCCGCAGTCGGCGCCGTT-3P (PacI site) ; oCJW4.2, 5P-
TGGCTTCCTTGGCCAGTAAAGAGAATGGCGA-3P (MscI
site) ; oCJW4.3, 5P-AGGAGGAACATATGAATGCAGCCG-
CGGT-3P (NdeI site) ; oCJW4.4,5P-TTGCGAATTCAAGCT-
TCAGCCCAACACACCCT-3P (EcoRI and HindIII sites) ;
oCJW4.5, 5P-TCGCCATTCTCTTTACTGGCCAAGGAAGC-
CA-3P (MscI site) ; oCJW 4.6: 5P-AGCGAAGGGCCCTAG-
GAAAGCGTTCCAGT-3P (AvrII site) ; CJW4.7: 5P-TTTGG-
CCAGGGGGCGCAGTGGTTCGGCATGG-3P (MscI site) ;
oCJW4.8: 5P-AACCTAGGTAGACATTGTCCCACCGCACC-
GGCG-3P (AvrII site) ; oCJW4.9: 5P-CATATGGCGGACCTGT-
CAAAGCTCTCCGAC-3P (NdeI site) ; oCJW4.10: 5P-AATGGC-
CAGGGAAGACGAACACCACCGGCGCGGA-3P (MscI site) ;
oCJW8.1, 5P-TTTGGCCAGGGCGCGCAATGGGCCGGGAT-
GGCGG-3P (MscI site) ; oCJW8.2: 5P-AACCTAGGTAGGC-
GGCGGTCCAGTCGACGGCCACG-3P (AvrII site).
5.4. Manipulation of DNA
Routine cloning and transformation procedures were as previ-
ously described for E. coli [51]. PCR was performed using Pfu
polymerase (Promega) according to the manufacturer’s instruc-
tions using a programmable Robocycler Gradient 40 (Stratagene,
USA). Automated DNA sequencing was carried out on double-
stranded DNA using an automated ABI 373A sequencer (Ap-
plied Biosystems).
5.5. Growth of S. erythraea
Transformation and propagation of S. erythraea was carried
out using standard methods [55^57]. SM3 was used as production
medium. For certain strains, it was supplemented with sodium
benzoate at 3 mM or benzoyl-NAC (7) at 1.4 mM [46]. SM3
medium: glucose 5 g, MD30E/glucidex 50 g, soya bean £our 25
g, beet molasses 3 g, K2HPO4 0.25 g, CaCO3 2.5 g, Milli-Q1
water to 1 l and pH adjusted to 7.0 with KOH.
5.6. Analysis of hybrid triketide lactone synthases in vivo
S. erythraea JC2-derived strains were grown at 30‡C in TSB
(Gibco) and SM3 media containing thiostrepton (5 mg/l ; Sigma).
S. erythraea cultures were grown for 5 days in 50 ml SM3 and 10
ml of this fermentation broth was then used for analysis. The
broth was ¢rst acidi¢ed to pH 3 with formic acid before being
extracted three times with an equal volume of ethyl acetate. These
crude extracts were then analysed by GC-MS on a GCQ instru-
ment (Finnigan, MAT). A Restek Corporation Crossbond1 5%
diphenyl-, 95% dimethyl-polysiloxane column was used with he-
lium as carrier gas. The constant gas velocity was 50 cm/s and the
injector temperature was 250‡C. The GC-MS was used in CI
(collision ionisation) mode with NH3 as reagent gas.
5.7. Chemical synthesis
5.7.1. Synthesis of (1S)-1-phenyl-but-3-en-1-ol (8)
To a solution of (3)-L-methoxy-diisopinylcampheylborane
(4.68 g, 14.8 mmol, 1 eq) in diethyl ether (12 ml), at 378‡C
allylmagnesium bromide (14.8 ml of 1 M soln. in diethyl ether,
14.8 mmol, 1 eq) was added dropwise with stirring. The solution
was stirred for 15 min at 378‡C, then allowed to warm to room
temperature over 1 h. The solution was re-cooled to 378‡C and
benzaldehyde (1.64 ml, 14.8 mmol, 1 eq) added. This solution was
stirred at 378‡C for 1 h, and then at room temperature for 1 h.
3 M sodium hydroxide (11 ml) and hydrogen peroxide (4.5 ml
30% soln.) were added and the solution re£uxed for 1 h. The
organic layer was separated and washed with water (15 ml), brine
(15 ml) and dried (MgSO4). The solvent was removed under
reduced pressure and the crude product subjected to distillation
and silica column chromatography (DCM 50% in 40^60 petrole-
um ether), total separation was not achieved, and the impure
product product 8 was carried through to the next step.
NH(250 MHz, CDCl3) 7.35^7.26 (5H, m, Ph), 5.79 (1H, ddt,
J 7.0, 10.2, 17.1 Hz, 2-H), 5.14 (2H, m, 2U1-H), 4.69 (1H, t, J 6.5
Hz, 4-H), 2.49 (2H, dd, J 6.7, 6.7 Hz, 3-H), 1.22^0.90 (impur-
ities) ; NC(62.5 MHz, CDCl3) 144.0 (C-5), 134.6 (C-2), 128.4,
127.5, 125.9 (C-6, C-7, C-8, C-9, C-10), 118.3 (C-1), 73.4 (C-4),
43.8 (C-3).
5.7.2. Synthesis of 4-[(tert-butyldimethylsilyl)oxy]-4-phenyl-
but-1-en (9)
To a solution of (1S)-1-phenyl-but-3-en-1-ol (8) (0.3 g, impure
approx. 2.0 mmol, 1 eq) in DCM (20 ml) at 378‡C were added
diisopropylethylamine (0.7 ml, 4.0 mmol, 2 eq) and tert-butyldi-
methylsilyl tri£ate (0.5 ml, 6.8 mmol, 1.1 eq) successively. The
resultant solution was stirred until the reaction was shown to be
complete by TLC (2 h), and the volatiles were removed under
reduced pressure. The crude product was puri¢ed by £ash column
chromatography (DCM) to yield 9 (0.51 g, 97%).
NH(500 MHz, CDCl3) 7.31^7.24 (5H, m, Ph), 5.77 (1H, m,
2-H), 5.04 (1H, m, 1-H), 4.98 (1H, m, 1-H), 4.68 (1H, dd, J 5.3,
7.1 Hz, 4-H), 2.43 (2H, m, 3-H), 0.89 (9H, s, t-Bu), 0.03 (3H, s,
1USi-CH3), 30.13 (3H, s, 1 x Si-CH3), 1.19^1.02 (impurities) ;
NC(100 MHz, CDCl3) 145.1 (C-5), 135.3 (C-2), 128.0, 126.9, 125.9
(C-6, C-7, C-8, C-9, C-10), 116.8 (C-1), 75.0 (C-4), 45.5 (C-3),
25.8 (Si-C(CH3)3), 18.2 (Si-C(CH3)3), 34.7 (Si-CH3), 34.9 (Si-
CH3).
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5.7.3. Synthesis of (3S)-3-[(tert-butyldimethylsilyl)oxy]-
3-phenyl-propionaldehyde (10)
To a solution of 9 (0.6 g, 2.3 mmol, 1 eq) in dioxane/water (12
ml, 5:1 dioxane:water) were added sodium periodate (1.81 g, 8.5
mmol, 3.7 eq) and a catalytic quantity of osmium tetroxide (0.292
g of 1% weight on polymer support, 0.005 eq). After 5 h no
reaction was observed, and a further portion of sodium periodate
was added (1.81 g, 8.5 mmol, 3.7 eq). The reaction was stirred for
14 h at room temperature, then ¢ltered, and the ¢ltrate extracted
with diethyl ether (200 ml). The organic solvents were removed
under reduced pressure and the crude product puri¢ed by silica
column chromatography (15% ethyl acetate in 40^60 petroleum
ether). To give 10 (0.21 g, 0.8 mmol, 35%). The acid was detected
as a major byproduct.
MS (ESI) m/z C15H24O2Na [M+Na], calculated 287.1437,
found 287.1438. NH(500 MHz, CDCl3) 9.79 (1H, t, J 2.3 Hz, 1-
H), 7.35^7.31 (5H, m, Ph), 5.21 (1H, dd, J 4.2, 8.1 Hz, 3-H), 2.85
(1H, ddd, J 2.7, 8.1, 15.7 Hz, 2-H), 2.62 (1H, ddd, J 2.0, 4.2, 15.7
Hz, 2-H), 0.87 (9H, s, t-Bu), 0.04 (3H, s, 1 x Si-CH3), 30.14 (3H,
s, 1USi-CH3), 1.22^1.14 (impurities) ; NC(100 MHz, CDCl3) 201.4
(C-1), 143.7 (C-4), 128.4, 127.6, 125.7 (C-5, C-6, C-7, C-8, C-9),
70.7 (C-3), 54.0 (C-2), 25.7 (Si-C(CH3)3), 18.1 (Si-C(CH3)3), 34.7
(Si-CH3), 34.9 (Si-CH3).
5.7.4. Synthesis of (4R)-3-[(2PR,3PS,4PR,5PS)-3P-hydroxy-
2P,4P-methyl-5P-[(tert-butyldimethylsilyl)oxy]-
5P-phenylpentanoyl]-4-phenylmethyl-2-oxazolidinone (11)
Dibutylboron tri£ate (0.26 ml, 1.0 mmol, 1.25 eq) was added
dropwise to a solution of (4R)-3-propionyl-4-phenylmethyl-2-ox-
azolidinone (0.22 g, 0.9 mmol, 1.1 eq) in DCM (5 ml, dry) at 0‡C.
To this solution triethylamine (0.16 ml, 1.2 mmol, 1.5 eq) was
added dropwise. The solution was stirred for 20 min at 378‡C,
then (3S)-[(tert-butyldimethylsilyl)oxy]-3-phenylpropionaldehyde
(10) (0.20 g, 0.8 mmol, 1 eq) was added. This solution was stirred
at 378‡C for 20 min and then at 0‡C for a further 2 h. The
reaction was quenched by addition of pH 7 phosphate bu¡er (1
ml) and methanol (3 ml). A mixture of methanol and aqueous
hydrogen peroxide (2:1, 3 ml 27 wt% H2O2) was added slowly
dropwise. The internal temperature of the reaction £ask was
maintained below 10‡C by cooling with an ice bath. The solution
(cloudy) was stirred for 1 h and the volatiles removed under
reduced pressure (25^30‡C). The resulting slurry was extracted
with diethyl ether (3U20 ml). Combined organic extracts were
washed with 5% sodium sulphite solution (40 ml, 2 M) until all
peroxides were destroyed. The aqueous layer was extracted with
ether (20 ml) and the resulting organic extracts combined, dried
(MgSO4), and concentrated under reduced pressure. The resulting
oil was subjected to £ash column chromatography (15% ethyl
acetate in 40^60 petroleum ether) to yield an impure yellow oil
(11) (0.27 g). The impure product was taken on to the next stage
in the synthesis.
MS (ESI) m/z C28H39O5NaNSi [M+Na], calculated 520.2505,
found 522.2490.
5.7.5. Synthesis of 4-hydroxy-3-methyl-6-phenyl-tetrahydropyran-
2-one (5)
Aqueous hydrogen peroxide (0.19 ml, 27 wt% in H2O, 1.5
mmol, 4.5 eq), and lithium hydroxide, (58 mg, 2.4 mmol, 7.1
eq) were added to a solution of (4R)-3-[(2PR,3PS,4PR,5PS)-3P-hy-
droxy-2P,4P-methyl-5P-[(tert-butyldimethylsilyl)oxy]-5P-phenylpen-
tanoyl]-4-phenylmethyl-2-oxazolidinone (11) (0.17 g, 0.34 mmol,
1 eq) in a mixture of tetrahydrofuran and water (3:1, 10 ml) at
0‡C. The resulting solution was stirred at room temperature for
20 min, and then at 40‡C until the reaction was complete by TLC
(4 h). The mixture was then cooled to 0‡C and quenched with
sodium sulphite (3.3 ml, 1.5 M, 15 eq). The volatile solvents were
removed under reduced pressure, and the aqueous slurry ex-
tracted with DCM (3U20 ml). The organic extracts were com-
bined and the solvent removed under reduced pressure. The chiral
auxiliary was separated from the acid by £ash column chroma-
tography (10% ethyl acetate in 40^60 petroleum ether).
The resultant acid (4 mg, 0.02 mmol) was stirred in a solution
of HCl (aq)/THF (10 ml, pH 4 HCl (aq)) and THF (2 ml) at
room temperature for 18 h, 40‡C for 4 h, then 80‡C for 4 h, when
the reaction was shown to have gone to completion by TLC. The
solution was extracted with ethyl acetate (3U10 ml). The organic
extracts were combined, washed with brine, dried (MgSO4), and
the solvent removed under reduced pressure, to yield the lactone
(5) as a colourless oil (2 mg, 0.1 mmol, 50% over ¢nal step).
MS (CI-NH4) 224 (M+18); NH(250 MHz, CDCl3) 7.43^7.25
(5H, m, Ph), 5.26 (1H, dd, J 3.1, 12.0 Hz, 5-H), 3.95 (1H,
dddd, J 4.0, 4.7, 9.8, 11.0 Hz, 3-H), 2.50 (1H, qd, J 7.1, 9.8
Hz, 2-H), 2.46 (1H, ddd, J 3.1, 4.0 13.5 Hz,1 x 4-H), 2.03 (1H,
ddd, J 11.0, 12.0, 13.5 Hz, 1U4-H), 1.48 (3H, d, J 7.1 Hz, 2-
CH3).
5.7.6. Synthesis of (2R,3S,4R,5S)-3,5-dihydroxy-2,4-dimethyl-
5-phenyl-n-pentanoic acid-N-lactone (6)
This was as described in Weissman et al. [58].
5.7.7. Synthesis of 2P-(acetylamino)ethylbenzoylthioate (7)
4-Dimethylaminopyridine (97 mg, 0.8 mmol, 0.2 eq) was added
to a solution of benzoic acid (0.50 g, 4.0 mmol, 1 eq) in dry DCM
(50 ml), followed by NAC (0.64 ml, 6.0 mmol, 1.5 eq) and
1,3-dicyclohexylcarbodiimide (4.4 ml of a 1 M solution in
DCM, 4.4 mmol, 1.1 eq) at 0‡C. The resulting solution was
stirred at 0‡C for 10 min and then 3 days at room temperature.
The solution was ¢ltered through Celite and eluted with ethyl
acetate. After ¢ltration through copper sulphate-impregnated sili-
ca, the crude product was puri¢ed by recrystallisation from ethyl
acetate, precipitated with 40^60 petroleum ether to provide a
white crystalline product (7) (0.79 g, 3 mmol, 75%).
m.p. 84‡C; Xmax (thin ¢lm)/cm31 1660 (CNO), 1552 (NH);
NH(250 MHz, CDCl3) 7.94^7.36 (5H, m, Ph), 6.47 (1H, s, NH),
3.48 (2H, dt, J 6.2, 6.2 Hz, CH2N), 3.18 (2H, t, J 6.2 Hz, CH2S),
1.93 (3H, s, COCH3); NC(62.5 MHz, CDCl3) 191.3 (C-1), 171.0
(NCO), 136.8 (C-2), 133.6 (C-5), 128.7, 127.2 (C-3, C-4, C-6,
C-7), 39.4 (CH2N), 28.4 (CH2S), 23.1 (COCH3).
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